SHANDONG LUKANG PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.68 CNY | -1.79% |
|
+0.39% | +7.56% |
| 05-29 | China Approves Lukang Pharma's Anti-Asthma Injection | MT |
| 04-23 | Shandong Lukang Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 968M | - | - | - | - | - | |
| 781B | ||||||
| 350B | - | - | - | - | ||
| 330B | ||||||
| 293B | ||||||
| 248B |
